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ABSTRACT
Aim To test both success and survival rate of implant placed 
simultaneously with sinus lift in atro-phic posterior maxilla 
with a residual bone height of less than 5 mm. 
Materials and methods A computer search strategy was 
developed for the following electronic databases: MEDLINE/ 
PubMed and EMBASE. All the relevant articles were screened 
involving controlled  clinical trials, randomized clinical trials, 
prospective cohort studies.  
Results The selection process yielded  12  studies, published 
between 1999 and 2016, 6 of which were  prospective, 1 was a 
randomized controlled trial, 5 were controlled studies. 
Conclusions Within the limitation of this systematic review, 
the qualitative data analysis revealed that the survival rate of 
implants placed in grafted sinus ranged from 61% to 100%; 
on the other hand, the success rate ranged between 75.3% 
to 94.8%. No significant differences were detected regarding 
different grafting materials used. In order to understand if the 
one-stage pro-cedure is an effective and predictable surgical 
alternative in critically resorbed maxillae, larger and well 
designed clinical trials are needed.
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INTRODUCTION
The rehabilitation of partially or totally edentulous 
patients with implant-supported prostheses has become 
a common practice in dentistry; the posterior maxilla 
frequently represents a challenging clinical situation 
caused by the lack of bone due to alveolar ridge 
resorption and maxillary sinus pneumatization (1). Thus, 
several surgical options have been proposed to establish 
an adequate bone volume for implant placement. 
The sinus floor elevation, using the standard lateral 
procedure,  to allow implant placement in the severely 
atrophic posterior maxilla was first presented in the 
late 1970s: the technique was introduced by Tatum and 
modified by Boyne and James and Wood and Moore (2,3). 
This procedure has been extensively used during the last 
20 years to successfully increase the dimension of the 
posterior maxilla for implant placement; according to this 
technique the access to the maxillary sinus is obtained by 
drilling a bone window in the lateral sinus wall using a 
small round bur, while ensuring that the sinus membrane 
remains intact. The sinus membrane is then carefully 
elevated, mobilised together with the attached bone 
window and rotated medially. This procedure is usually 
performed in conjunction with a variety of bone grafting 
material, including autogenous bone from the iliac crest, 
the mandibular chin, the mandibular ramous or the 
calvarium, but also with bone substitutes used alone or 
in combination with autogenous bone. For this protocol, 
several studies have claimed success rates >90%, with 
control periods ranging from 1 to 9 years of follow-up 
(4,5). 
Nowadays two main techniques of sinus lift for dental 
implant placement are in use: a two-stage protocol with a 
lateral window approach, followed by implant placement 
after a healing period; or a one-stage technique using 
either a lateral or transalveolar approach. The decision 
making process is mainly based on the amount of 
residual bone available and the possibility of achieving 
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Types of publications
The present review searched for prospective cohort 
studies,  controlled clinical trials (CCTs) and Randomized 
controlled clinical trials (RCTs) that analyzed both survival 
and success rate of implants inserted with simultaneous 
sinus floor  elevation, with a residual bone height of less 
than 5 mm. 
Study variables 
The primary outcome measure selected for this review 
was the survival rate of the dental implants inserted 
simultaneously with the maxillary sinus floor elevation 
in the posterior region of the maxilla with a residual 
bone height of 5 mm or less; this variable included 
thefollowing.
1.  Survival of implant: implant mobility,  persistent pain, 
presence of continuous peri-implant radiolucency, 
followed by implant removal due to progressive 
marginal bone loss and infection  were considered as 
biological failure.
2. Survival of implant prosthesis: any mechanical 
complications such as implant fracture or platform 
deformation (mechanical failure) were included .
Source of information and search strategy
for the identification of studies to be involved in this 
review, a computer search strategy was developed for 
the following electronic databases: PubMed/ MEDLINE, 
EMBASE and Cochrane Library. The search was limited 
to studies involving human subjects, published in English 
from  January 1998 to October 2017. A further manual 
search was performed on the following journals: The 
International Journal of Oral and Maxillofacial Implants, 
Implant Dentistry, The international journal of oral 
and maxillofacial surgery, The International Journal 
of Periodontics and Restorative Dentistry, Clinical Oral 
Implants Research, Clinical Implant Dentistry and Related 
Research, Journal of Dental Research, European Journal 
of  Oral Implantology, Periodontology 2000, Journal of 
Periodontology, Journal of Clinical Periodontology. The 
search was completed by adding a manual review of the 
references of the included studies. 
The following search string was applied: (“residual bone 
height” OR “atrophic maxilla” OR “atrophic posterior 
maxilla “AND “sinus lift “OR” sinus floor elevation” OR 
“maxillary sinus augmentation”) OR (“lateral window” 
OR “maxillary sinus grafting” OR “lateral approach” OR 
“sinus graft” AND “dental implants”  OR “one stage sinus 
elevation”) OR (“maxillary sinus lift” OR “sinus lift” AND 
“implant placement” OR  “immediate implant placement”) 
OR (“dental implant survival rate” OR  ”dental implant 
failure”).  
Study selection 
Two authors  (CD and NN) independently screened the titles 
derived from the extended search, based on the inclusion 
criteria; disagreements between the  two examiners 
primary stability for the inserted implants. Evidence from 
the literature suggests that the minimum bone height 
needed to install the implants in the same surgery is 
4-5 mm (6,7,8,9). Several clinical studies confirm these 
data: in a study published by Geurs et al. in 2001 (10) 
a statistically significant difference in implant loss was 
demonstrated, where residual bone height was 4 mm or 
less, when  compared  with 5 mm or greater original bone 
height.
Various systematic reviews have recently reported that 
simultaneous and delayed implant placement  have 
displayed  similar survival rates (11); however it must 
be highlighted that these studies involved many factors 
that may create a bias, such as the type of graft used 
for augmentation, the surgical technique and the type 
of implants (12). A recent prospective study evaluated 
survival and success rates of the implants simultaneously 
placed into grafted sinus using rough-surfaced implant 
(13); a total of 217 consecutive sinus lifting through 
lateral approach and 462 simultaneous implants were 
installed. Of the 462 implants, 262implants were 
installed in posterior maxilla less than 4mm RABH and 
two hundred implants were placed in over 5mm RABH. 
The cumulative survival and success rates were 98.91% 
and 96.54%; no statistically significant differences were 
observed in success rate between group 1 and group 2 
(P=0.3135).  The Authors concluded that sinus lifting 
with simultaneous implant placement could be used to 
treat atrophic maxilla in patients with minimal RABH 
when initial stability could be obtained by using taper 
designed implants. However even if a good success 
rate is shown,  in patients having residual bone height 
between 1 to 3 mm below the maxillary sinus there 
might still be a slightly higher risk for implant failures 
when performing a 1-stage lateral sinus lift procedure. 
Therefore, the aim of the present systematic review was 
to assess both survival and success rates of implants 
placed in grafted sinus, with an average residual bone 
height of 5 mm or less, when performing a 1-stage 
surgical procedure. 
 
MATERIALS  AND METHODS 
Protocol
A detailed protocol was designed according to the 
PRISMA-p (Preferred Reporting Items Systematic 
review and Meta-Analyses) statement (14,15,16,17) 
for reporting systematising reviews and AMSTAR 
checklist (18), in order to improve the quality of the 
search. Moreover the methodology of this review was 
performed according to the Cochrane Handbook for 
Systematic Reviews of Interventions (19). The focus 
question was: What is the survival rate of dental 
implants inserted simultaneously with maxillary sinus 
lift, in atrophic posterior maxilla showing a residual 
bone height of 5mm or less? 
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PRISMA 2009 Flow Diagram 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(6): e1000097. doi:10.1371/journal.pmed1000097 
For more information, visit www.prisma-statement.org. 
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FIG. 1 The PRISMA flow diagram of the selection process.
were resolved through discussion  and a Cohen’s Kappa 
coefficient was calculated as a measure of agreement 
between them. As described in Figure 1, the PRISMA flow 
diagram shows an overview of the selection   process: 
on the whole 3252 titles were screened; furthermore, an 
additional  hand search, included 8 articles. Following this, 
all the abstracts of the titles selected by both authors, 
were searched and screened to ensure they met all the 
inclusion criteria; again disagreements  were resolved by 
discussion between the two readers. Finally the selection 
of all the articles, based on the inclusion/exclusion 
criteria, was made for the full text articles. The screening 
of each section of the paper (materials and methods and 
results) was  again carried out independently by the two 
examiners. All the rejected studies (independently of the 
selected step) were recorded in the “Excluded studies” 
table and the reasons for exclusion were then described. 
All disagreements between the two reviewers were 
resolved by discussion, and Cohen’s Kappa coefficient was 
used as a measure of agreement between them:   the K 
value was 0.66 at title level and 0,76 at abstract level, 
respectively. Finally, 12 studies were included in this 
review, as described in Table 1. 
Inclusion criteria
The review of the articles was accomplished in two 
consecutive screening steps. In the first screening, two 
independent review authors screened all the titles and 
abstracts to eliminate the irrelevant articles or reviews. 
While, the second screening was aimed at collecting 
only the pertinent papers: each  examiner reviewed 
the complete text of all articles that passed the first 
screening, using the  following including  criteria: 
human trials with a minimum amount of 20 patients; 
studies describing at least 15 immediate implants 
inserted simultaneously to the sinus for elevation, with 
a residual bone height of a maximum of  5mm; access 
to the sinus antrum by the lateral window procedure; 
trials with a follow up interval of at least 1 year after 
functional loading of the implant placed in the region 
of the grafted sinus; clearly defined survival or success 
rate for the implants placed in the region of the sinus 
floor augmentation; trials describing both the type of 
grafting material used and the implant surface features. 
Exclusion criteria 
Publication concerning in vitro studies or animal studies 
were excluded.  All the human studies not fulfilling 
all  the above inclusion criteria, were also excluded. 
In addition, trials were eliminated if: the publications 
did not clearly report the baseline residual bone height 
amount; the papers were  narrative reviews; personal 
communication was included in the paper. Moreover 
studies with inadequate description of surgical 
procedure or length of the follow up period were 
excluded.
Data extraction and management 
For each trial, the following informations from the 
included  articles were collected: author(s), year 
of publication, study design, details of participants 
including demographic characteristics, number of 
inserted implants, residual bone height, surgical 
procedure details (implant type, graft type), follow up 
period, outcomes (survival/success rate) description, 
number and type of complication. Particularly, 
Schneiderian membrane perforation, infection and 
graft loss  resulting in implant positioning inability were 
specifically considered as possible complications.
Quality assessment and risk of bias  
The methodological quality of all the included studies 
was independently evaluated, in duplicate, by the 
two reviewers; the  Cochrane Collaboration’s tool for 
assessing risk of bias was applied for RCTs and CCTs. 
The following criteria were considered: sample size 
determination, randomization sequence (selection bias), 
allocation concealment (selection bias), operators and 
partecipant blinding (performance bias), incomplete 
outcome data (attrition bias), selective outcome 
reporting (reporting bias), group imbalance and follow 
up duration. A judgement as to the possible risk of 
bias on each domain was made from the extracted 
information, rated as “high risk” or “low risk” , when 
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TABLE 1 Study and patient characteristics of the included studies.
Author, year Study design Implant system implant design Group treatment 
Number of 
patients
Number of  
implants
Survived 
implants
Failed 
implants
loading 
protocol  
(month)
Mean 
age
Grafting material
Mean 
follow-up
Success/survival 
rate 
evaluation 
method
Simonpieri 
et al, 2011
PROSPECTIVE 
COHORT 
STUDY, single 
centre 
ASTRA-TECH 
INTRA-LOCK
conical-inter-
analhexagn 
intern hex 
connection
SFE and 
simultaneous 
implant 
placement  
20 52 52 0 6 59,8 L-PRF CLOTS
72  
(24-72) 
m
survival 
100% (Misch) 
opt
Peleg  
et al, 1999
PROSPECTIVE 
COHORT 
STUDY, single 
centre 
nr
SFE and 
simultaneous 
implant 
placement  
63 160 160 0 9 57,5
50% ABG + 
50% DFDBA
31  
(23-48)m
survival 
100% (self 
defined )
opt
Kahnberg 
et al, 2001
PROSPECTIVE 
COHORT 
STUDY, single 
centre 
branemark 
systemm,  
nobel biocare
Conical, 
external 
hexagon 
connection
SFE and 
simultaneous 
implant 
placement  
26 93 64 29 6 56
ABG BLOCK 
(ILIAC)
48  
(36-60)m
survival 
61,2 % (self 
definied )
opt
Canullo et 
al, 2010
PROSPECTIVE 
COHORT 
STUDY, multi 
centre
sweden 
&martina
conical , 
internal 
connection
SFE and 
simultaneous 
implant 
placement
30 67 65 2 3 58,3
HA + 
SILICE GEL 
(nanobone)
24 m
survival 
97,01 % (self-
definited)
Manso et al, 
2010
PROSPECTIVE 
COHORT 
STUDY, single 
centre 
STERI-OSS 
SYSTEM; 
BRANEMARK 
SYSTEM 
MK-III; 
3i-OSSEOTITE
Conical, 
external 
hexagon 
connection
1 group: 
autogenous 
bone and 
bioactive 
resorbable 
graft
45 160 158 2 3 nr
autogenenous 
( retromolar)+ 
SBRB (syntetic 
bioactive 
resorbable 
graft)
61,7 
 (20-132) 
m
survival 
98% success 
94,8% 
(Albrektsson) 
ct scans
Cha et al, 
201213
CCT, single 
centre
IMPLANTIUM, 
DENTIUM Co, 
Seul Korea 
conical , 
internal 
connection
RBH < 5 mm 
RBH > 5 MM
217
262  
200
255 
191
7 9 6 NR BIOSS
57±15,6 
(36-98)
CRS 97,3%   /
(Albrektsson)  
/ 98,91%CRS  
95.5&   / 
(survival rate)
opt and 
periapical
Johasson et 
al., 1999
CCT, single 
centre
NOBEL  
BIOCARE 
Conical, 
external 
hexagon 
connection
inlay - block 
no bone 
grafting 
39 37
131
+123 
206
110  
200
21 6 6 56
ABG BLOCK 
(iliac)
36
success75,3 
% (CRS) 
success 
93.1% (CRS) 
(Albrektsson)
opt
Khouri, 
1999
CCT, single 
centre
nr nr
bone graft 
from retro 
molar 
area bone 
graft from 
symphysis
69 147 467 439 28 9 45,5
autogenenous 
(retromolar or 
synphysis)
49
success 94 % 
(Albrektsson)
opt
Rodriguez 
et al, 2003
PROSPECTIVE 
COHORT 
STUDY, single 
centre 
nr nr
SFE and 
simultaneous 
implant 
placement
15 70 65 5 4 nr DPBB+ PRP 6-36 92,9 ct scans
Mendonca-
Caridad et 
al, 2013
CCT, single 
centre
STRAUMANN 
SLA
conical 
internal 
connection 
SFE and 
simultaneous 
implant 
placement 
HSB <5mm vs 
HSB>5mm  
15 46 44 2 4-6 53,4
calvaria+ 
PRP+B-TCP
12,8 mon 
95,7% 
/97,8%
opt
Di Lallo et 
al, 2014 
CCT, single 
centre
Neoss  
Proactive
conical , 
internal 
connection
1-stage +SFE 
3mm 2-stage 
+SFE <3mm
13 9 10 9 10 0 6 59
Bioss + ABG 
50+50
1y 100% nr
Felice et al, 
2014 
RCT 
muticentre 
GEASS
conical 
internal 
connection 
1-stage+SFE 
2-stage+SFE
30 30 66 69
63  
68
3 1 4
56  
54
BIOSS + 
MEMBRANE 
1y
95,45%  
98,5%
opt and 
periapical
they met all or all but one or more criteria respectively. 
Table 2 summarises  the results of the quality assessment 
estimated for  the involved studies. While prospective 
studies were analysed using the NOS (Newcastle Ottawa 
scale), as illustrated in Table 3.
RESULTS
Study selection
As the number of randomized controlled clinical trials 
(RCTs) was found to be numerically limited (only 
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TABLE 2 Risk of bias assessment for RCT and CCT (Cochrane Scale).
Felice et al Cha et al Johansson et al Khoury 
random sequence 
determination ( 
selection bias) 
1 low risk high risk high risk high risk 
2
a computer a generated 
restricted random list was 
created 
no randomisation: group 1 
included patient with RABH 
<5mm; group 2 included 
patients with RABH >5mm
no randomisation: 
the donor site was 
established with 
preoperative radiographs 
no randomisation 
allocation 
concealment 
(selection bias)
1 low risk high risk high risk high risk 
2
after flap elevation, the 
sequentially numbered 
opaque sealed envelope 
containing the group 
allocation code was opened 
- - -
blinding of 
participant and 
researchers 
1 high risk high risk high risk high risk 
(performance bias) 2
both patient and surgeon 
were aware of the allocated 
arm and would know 
the randomised type of 
performed treatment 
both patient and surgeon 
were aware of the allocated 
arm 
both patient and surgeon 
were aware of the 
allocated arm 
both patient and 
surgeon were 
aware of the 
allocated arm 
blinding of outcome 
assessment 1 low risk high risk high risk high risk 
(detection bias) 2
One dentist not involved 
in the treatment of the 
patients, made all clinical 
assessments without 
knowing group allocation, 
therefore outcome assessor 
was blind.
not reported no not reported 
incomplete outcome 
data ( attrition bias) 1 low risk low risk low risk low risk
2 losses to follow up were reported and specified 
losses to follow up were 
reported and explained 
losses to follow up were 
reported and specified 
losses to follow 
up were reported 
and specified 
selective reporting 
(reporting bias ) 1 low risk low risk low risk low risk
2 all selected outcomes were reported 
all selected outcomes were 
reported 
all selected outcomes 
were reported 
all selected 
outcomes were 
reported
group imbalance 1 high risk high risk high risk high risk 
2 implant of different type were used
implant of different type 
were used 
implant of different type 
were used 
implant of 
different type 
were used 
sample size 1 high risk high risk high risk high risk 
2 no sample size calculation was performed 
no sample size calculation 
was performed 
no sample size calculation 
was performed 
no sample size 
calculation was 
performed 
follow up time 1 low risk low risk low risk low risk
2 patients were recalled every 6 months for 1 year
the mean duration of follow 
up was 36-98 months.
the mean duration of 
follow up was 3 year 
the mean follow 
up time was 6 
years
clinician bias 1 low risk low risk high risk low risk
2
the study addressed and 
specified each of the 3 
surgeon performed the 
interventions; the same for 
the prosthetic treatment
one surgeon performed all 
the interventions 
one or two surgeons 
treated the patients 
one surgeon 
performed all the 
interventions 
radiographic 
outcome 1 low risk low risk high risk high risk 
2
the indipendent 
investigators performed the 
radiographic measurements
an independent examiner 
interpreted all radiographs not specified not reported 
1: authors’ judgement 
2: explanation for judgement
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one), different levels of evidence including controlled 
clinical trials (CCTs), prospective cohort studies (CS) 
were involved. The electronic search identified a total 
of 3252 titles; Figure 1 describes the workflow process 
of identifying the 12 articles included in the study: one 
randomized controlled clinical trial (20), 5 controlled 
clinical trials (13,21,22,23,24), and 6 prospective cohort 
studies (25,26,27,28,29,30). All the selected studies 
features are shown in Table 2. The first article was 
published in 1999; the median year of publication is 
2001. The overall amount of the implants inserted in 
these studies is 1777, including 796 patients between 
18 and 80 years of age; all the involved trials were 
mainly conducted in institutional environments such as 
universities or specialist clinics.
Included studies 
The 12 studies that met the inclusion criteria are 
illustrated in Table 1; due to the absence of appropriate 
RCTs, controlled clinical trials and prospective cohort 
studies were included in the present systematic review. 
The results were analysed separately for  different  groups 
of studies. However, the annual failure rate did not reveal 
statistically significant differences between the groups, 
thus displaying a minimal study design effect. 
Exclusion of studies 
The main reasons for excluding studies (reference list 
in Figure 1), after the full text was obtained, were as 
follows.
1. No information regarding residual bone height.
2. Sample size <20 inserted implants.
3. Only implants placement according to the 2-stage 
protocol.
4. Combination of grafting techniques.
5 Not reporting on sinus floor elevation procedure.
6. Sinus augmentation via transalveolar approach.
7. Residual bone height > 5mm.
8. No described survival data or no distinction of 
survival data between implants placed in sites 
treated with different grafting techniques.
9. Mean follow up period <1 year.
Characteristics of the studies
Table 1 describes the most important characteristics of 
the included studies. On the whole, 796 partially  or 
totally edentulous patients showing a  severely resorbed 
posterior maxilla  (less then 5mm) were involved in the 
included studies. The mean size of the study samples 
was 128 implants and ranged from 9 to 467 inserted 
implants; the mean age of patients was 41.9 years (SD= 
23.6) and none of the studies focused on the smoking 
habits of patients. The loading protocol was 6 months 
in 6 studies, 9 months in 2 studies; only in 2 studies 
the waiting time before loading the inserted implants 
was 3 months and 4 months respectively. Dealing with 
the radiographic evaluation method, in 2 studies (13,20) 
both periapical radiographs (long-cone paralleling 
technique) and panoramic radiographs were taken; 
only 2 studies performed CT scans at follow up visits 
(25,30). Conversely all the remaining studies used only 
panoramic radiographs. 
Statistical analysis
For descriptive statistics, the average of implant survival 
were calculated using the data extracted from the 
selected studies; data were analysed using SPSS version 
18 for Windows (SPSS Inc., Chicago, IL, USA). 
For each study, the estimated failure rate and implant 
survival rate after 1 year (%) were assessed. In this 
systematic review, an implant failure was defined as 
each implant from a cohort that was removed because 
of loss of integration, implant mobility, symptoms as 
pain, neuropathies, paraesthesia (31). Failures were 
directly extracted from the publications, as well as 
the mean follow-up time, supplemented as adjunctive 
information from the author of the original papers or 
calculated from the original database. 
selection comparability total
authors , 
years
Representativeness 
of the exposed 
cohort 
Selection 
of external 
control 
Ascertainment 
of exposure 
Outcome of 
interest not 
present at 
start 
Comparability 
of cohorts on 
the basis of the 
design
or
analysis
Assessment 
of outcome
was 
follow-up 
long enough 
for outcomes 
to occur ?
adequacy 
of follow-
up of 
cohorts
Manso et 
al,2010
  * * * * * * * * 8/9
Simonpieri 
et al,2011
0 * * * * 0 * * * 7/9
Peleg et 
al,1999
* * * * * 0 * * * 8/9
Kahnberg 
et al, 2001
* * * * ** 0 * * 8/9
Canullo et 
al,2010
* 0 * * * 0 * * * 7/9
Rodriguez 
et al,2003
* * * *  0 * * * 7/9
TABLE 3 Newcastle- Ottawa quality assessment scale.
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Quality assessment and risk of bias of the included 
studies 
Risk bias and quality were assessed by using two 
different analysis scales, according to the study design, 
as described in Table 3 and 4.  The included randomized 
controlled trial was well conducted regarding 
randomization, allocation, data collection, blinding of 
outcome assessment reporting a low risk of bias. On the 
other hand the study showed an high risk in the blinding 
of participant and surgeon (performance bias) and for 
the group imbalance. Instead none of the included 
prospective cohort studies achieved the highest score 
on the NOS; however all studies scored 7 or 8 points, 
revealing an overall low risk of bias. 
Grafting material 
Data from all the included studies could be allocated to 
at least one of 3 subgroups: 
1)  autogenous bone alone; 
2) autogenous bone in combination with bone 
substitutes (alloplasts or xenografts); 
3) bone substitutes alone. 
Within the first subgroup, both block and particulated 
grafts harvested from different donor sites were 
included. Autogenous bone has long been considered 
the gold standard (32), due to its osteoconductive, 
osteoinductive and osteogenic properties. Intraoral 
donor sites (chin and ramus) are convenient but yield 
limited volume; whereas extraoral donor sites (iliac 
crest, tibia, ulna, rib and calvarium) increase surgical 
complexity and are associated with significant and 
often under-reported morbidity and scarring. In 2 
studies autogenous bone graft harvested from the 
iliac crest was used (23,28); the mean survival rates 
assessed for this subgroup was 77.1 (SD=14.9). In 
two studies the autograft was harvested along the 
external oblique line of the mandibular ramus and then 
particulated using a manual milling machine (24,25). In 
the subgroup using a combination of grafts, 2 different 
bone substitutes were used as grafting materials to 
reduce the  volume of bone harvested from different 
donor sites: SBRB, Syntetic bioactive reservable graft 
(25), DFDBA, demineralized freezedried bone allograft 
(27) and Beta-tricalcium-phosphate(32); particularly 
in this study a laminated calvaria scaffold was used 
as autogenous grafting material. This group showed a 
mean success rate of 99%. In the subgroup using only 
bone substitutes, 2 different grafting  materials were 
applied: DBBM deproteinised bovine bone material 
(13,20), L-PRF leucocyte and platelet rich fibrib clot (26) 
and HA and silice gel (nanocrystalline hydroxyapatite 
granules embedded in a silica gel matrix) (29). In this 
group the assessed mean survival rate was 95%. It 
must be highlighted that long term reports are more 
numerous for autogenous bone graft than for other 
subgroups; conversely, long term studies using bone 
substitutes alone are still scarce. 
Survival rate of implants 
In this review, all the selected studies reported the 
survival rate of the implants. We directly used  the 
data of survival rate that was defined as the implant 
remaining in situ during the overall observation period. 
35 The reported survival rate for all the included 
studies ranged between 96% and 100% after a mean 
observation period of 12-18 months; in this review a 
critical source of heterogeneity was the criteria used 
to describe implant survival/ success rate, which differs 
from paper to paper. Furthermore , some articles did 
not clearly report those criteria, so the amount of 
failure data was directly extracted without attempting 
to unify the overall success and survival criteria. 
However,  the most important parameters considered as 
acceptable according to Albrecktsson and colleagues’ 
(31,34) success criteria were the following:  marginal 
bone loss, implant mobility, peri-implant infection 
with suppuration , persistent pain. In one study (26) 
the survival rate of the inserted implants was evaluated 
by using the clinical and radiographic evaluation 
parameters  of Misch et al. (34). Instead, one paper 
(13) clearly declared that the survival rate calculation 
was performed according to the Kaplan-Meier survival 
analysis: implant survival was defined as the length 
of time of implant survival from  the date of implant 
installation to the date of implant failure. Furthermore, 
implant failure rates were  also calculated according 
to the performed surgical procedure (one stage or two 
stage): in 1 study 20 patients were allocated into two 
groups, comparing the one stage technique with the 
2-stage technique, with implant placement delayed by 
4 months. In all other studies the implants were inserted 
only according to the  one stage technique; implants 
inserted with a one stage technique showed a slightly 
higher failure rate, even if there were no statistically 
significant differences. Several clinical studies 
showed similar results, confirming that immediate 
implant placement demonstrated a successful surgical 
approach, when the bone residual height is moderate, 
but adequate in order to achieve primary stability 
(36,37,38). Particularly, in a 1 to 6 year follow up study 
(39) the authors suggested that the one stage protocol 
results in a predictable bone formation with a high 
implant survival rate of 97.6%, even without using 
bone graft. 
Biological and technical complications 
Biological complications were classified as intrasurgical 
(membrane perforation) or post-surgical complication 
(acute sinusitis). No biological or technical intrasurgical 
complication were described or specified in 4 studies 
(21,23,28,30). Perforation of the sinus membrane 
was the mostly reported intraoperative complication, 
although none of the studies showed any correlation 
between the  complication and the implant  treatment 
outcome. Particularly in one study, a total of 35 of 
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two 217 sinus membranes were perforated and 68 of 
462 implants were inserted in perforated sites: only 3 
implants of these failed; according to chi square test 
with Fisher’s exact test, there were no statistically 
significant differences in success rate between 
implants inserted in perforated or non-perforated 
sinuses (p=0.7162) (13). All the perforated membranes 
were sealed by using a collagen membrane, as a 
coverage. Only in one study this kind of complication 
was related to a graft infection (20); dealing with post 
surgical complication, one study reported 5 sensory 
disturbances due to injury of incisive nerve branch, 
during graft harvesting stage (27); in addition one 
study reported sinusitis (22).
DISCUSSION 
The purpose of this systematic review was to evaluate 
survival and success rates of implants simultaneously 
placed in grafted sinus, with an original residual bone 
height of less than 5mm.  Studies with similar design 
were compared and in the overall survival rate, no 
statistically significant differences were found, with 
regard to the evidence level ; these data are consistent 
with  previous  reviews (40,41); it must be noted that this 
systematic review, due to the absence of appropriate 
RCTs, also involved articles of lower evidence levels, 
such as controlled trials. The comparison of data 
from different surgical approaches, varying follow 
up times, dissimilar success and survival criteria, 
different grafting materials and implant macro and 
micromorphologies always affects the validity of the 
statistical evaluation. For this reason, the main aim of 
this review was to select the most significant variables, 
evaluating their effect on the overall database.
Only studies with at least 10 patients monitored  at 
least for 12-month follow up after  implant loading 
were included; regarding the surgical procedure, only 
studies based on lateral window approach to enter 
the maxillary sinus were selected; different surgical 
procedures, such as osteotome sinus elevation, were 
excluded because they might have represented an 
important source of bias. Furthermore, studies that 
did not report the residual bone height or studies 
with an initial residual bone height, at implant site, of 
more than 5 mm were not included. In evaluating  the 
factors mainly involved in affecting survival or success 
rate of implants, it should be noted that only 4 studies 
(13,21,25,29) reported data regarding the insertion 
torque and the crown/implant ratio, as a potential 
risk factor for failure rate. Particularly one study (20) 
reported that in the 2 stage procedure group, more 
implants were inserted with a torque higher than 
30cmN (97.9% versus 18.2%) while more sites were 
characterized by soft bone quality at stage-1 implants 
(81% versus 0%). Conversely,  the controlled  clinical 
trial by Cha et al. (13) reported that, if the initial 
stability of 15 Ncm was not gained by the torque 
gauge, a larger diameter implant was used. No other 
studies report any information regarding the insertion 
torque. In one study (29) resonance frequency analysis 
(RFA) was performed to monitor implant stability 
changes over time: the implant stability quotient (ISQ) 
was measured at the first surgery (T0), at the abutment 
connection (T1) and after 2 year follow up (T2). Data 
analysis showed statistically significant differences 
(P<0.005) regarding ISQ mean values, between T1 and 
T0, as well as T1 and T2; after 24 months of prosthetic 
loading, only 2 implants were lost. Particularly, both 
insertion torque and RFA are considered predictive 
methods  when  assessing implant osseointegration 
at implant placement, as  shown in a recent study. 
(40). None of the selected studies emphasised the 
importance  of the crown/implant ratio, as possible 
factor affecting the success or survival implants 
rate. This prosthetic paramether   is considered by 
clinicians as a potential  risk factor for biomechanical 
complication and higher failure rate in areas with soft 
bone, even if a potentially greater C/I ratio has not yet 
been demonstrated to result in increased biological 
complication (41). Furthermore, longer dental implants 
inserted in augmented and grafted sinus may have an 
increased failure rate (up to 17%, within 3 years of 
follow up) when compared to implants placed in native 
bone (36). In a recent review (42) the calculated mean 
survival rate of shorter implants was 99% (95% CI 
96.4-99.8%) and therefore similar to the mean survival 
rate of longer implants in the augmented sinus (99.5%; 
CI 97.6-100.0%). One must consider the important 
limitations of these findings that still include: the 
relatively short follow up period; the lack of studies 
specifying the prosthetic reconstruction type: in all 
but one clinical study, shorter dental implants were 
splinted and not restored by single crowns. 
A positive or negative influence of splinting implant 
prosthetic reconstructions has not yet been still 
demonstrated, even if splinting adjacent implants 
may improve the stability of the implant at osteotomy 
site, thus controlling all the micromovements at the 
interface (43). Finally, regarding the surgical procedure, 
only one study (20) reported the comparison between 
the 1-stage and the 2-stage technique, while all other 
studies involved only the one stage technique. It should 
be noted that, even in one stage procedure studies, 
the failure rate is influenced by different variables: 
the main potential disadvantage is the possibility of 
not being able to stabilise the inserted implants in 
a minimal bone height; however in these cases, it is 
always possible to shift during the surgery to a 2-stage 
procedure, or the insertion of implants of greater 
diameter (13), even if higher implant failure probability 
may be expected (20). On the other hand, the most 
important advantage of the 1-stage procedure is the 
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possibility of shortening the healing time by at least 
50%. Implant survival rates reported in this systematic 
review are favourably comparable with data obtained 
according to the 2-stage procedures: the study by 
Felice et al. (20) suggested that in patients having a 
residual bone heigh between 1 to 3 mm, there might be 
a slightly higher risk of implant failure when performing 
the 1-stage procedure. Nevertheless, there is a small 
quantity of trials comparing the 2-stage surgical 
procedure, as reported in a recent systematic review 
by Esposito et al. (44). A study by Wannfors et al. (45) 
evaluated this comparison at 3-years after loading;  40 
edentulous patients with more than 2 mm but less than 
7 mm of residual bone height were involved in the study. 
In the first group, the 1-stage sinus lift was performed, 
using monocortical iliac bone blocks fixed with 2 
implants; in the control group, patients underwent 
the 2-stage procedure, with particulate bone from 
the iliac crest. The following outcome measures were 
studied: implant failure, prosthesis failure, marginal 
bone level changes and complications (intra-operative 
sinus membrane perforation). Data analyses showed 
no statistically significant differences between the 2 
groups.  A systematic review by Wallace and From (46) 
identified  8 clinical trials focusing  on the  comparison 
between the 2 procedures: the implant survival rate 
for the combined simultaneous implant placement and 
delayed placement studies  were 89.7% and 89.6% 
respectively. In evaluating these data, it must be kept 
in mind the large amount of multiple confounding 
variables affecting the results of non controlled clinical 
trials: used biomaterial, type of inserted implant 
(machined versus rough surface) and presurgical 
residual alveolar  bone height (RABH). It is reasonable 
to consider the RABH as a key factor for clinicians  in 
choosing a simultaneous or delayed implant placement, 
because it allows for implant primary stability; however 
the relevance of the initial residual bone height is a 
controversial question. Peleg et al. (47) reported 96.4% 
of survival rate for simultaneous placement of implants 
in sinus grafts with a 1 to 2mm RSBH and 98.9% 
for implants inserted >5 mm bone, thus confirming 
previous reports (27, 48).
CONCLUSION  
The most significant limitation of this systematic review 
is the different evidence level of the  involved studies; 
particularly, the absence of appropriate randomized 
controlled clinical trials provided a lower level of 
evidence, thus requiring the inclusion of prospective 
and retrospective cohort studies. Within these 
limitations, the following conclusions can be drawn. 
The survival rate of implants placed in grafted sinus 
ranged from 61% to 100%; instead the success rate 
varied between 75.3% to 94.8%. Nevertheless it must 
be highlighted that both success and survival rate have 
been described using different criteria, thus providing 
a source of heterogeneity; furthermore  some articles 
did not clearly report the criteria used to describe the 
implant survival rate. 
No significant differences were detected about groups, 
regarding used grafting materials; these data are 
consistent with results obtained in a recent review 
by Esposito et al. (42). In order to understand if the 
onestage procedure is an effective and predictable 
surgical alternative in critically resorbed maxillas, 
larger and well designed clinical trials are needed.  
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